Related Experiment Video
Updated: Jul 15, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Cell cycle regulation targets of MYCN identified by gene expression microarrays
Emma Bell1, John Lunec, Deborah A Tweddle
1Northern Institute for Cancer Research, University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom.
Background:
We have previously shown that MYCN knockdown causes a G1 arrest in MYCN amplified (MNA), p53 wild type (wt) and p53 mutant MNA neuroblastoma cell lines, with increases in p21(WAF1) and hypo RB in p53 wt cell lines.
Hypothesis:
MYCN acts by inhibiting p21(WAF1), and also by p21(WAF1) independent mechanisms to override the G1 checkpoint in exponentially growing cells.
Methods:
Genes potentially regulated by MYCN were identified using gene expression microarrays in p53 wt MNA IMR-32 and p53 mutant MNA SKNBE(2c) neuroblastoma cell lines treated with MYCN or scrambled siRNA. Results were validated using qRT-PCR and confirmed using the regulatable MYCN expression system (SHEP Tet21N).
Results:
MYCN knockdown altered the expression of several cell cycle related genes. SKP2 was down regulated in both cell lines, and up regulated in MYCN+ Tet21N cells. Expression of the WNT antagonist DKK3 increased in both cell lines and decreased in MYCN+ Tet21N cells. Expression of CDKN1C (p57(cip2)) and TP53INP1 also increased after MYCN knockdown.
Conclusions:
MYCN may override the G1 checkpoint through down-regulation of SKP2 and TP53INP1 resulting in reduced p21(WAF1) expression in p53 wt cell lines, and in addition may act through the WNT signaling pathway in a p53 independent manner.
Insights
MYCN knockdown induces cell cycle arrest in neuroblastoma by affecting cell cycle regulators like SKP2 and TP53INP1. This impacts p21(WAF1) expression and WNT signaling, offering insights into neuroblastoma progression.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Cycle Regulation
Background:
- MYCN amplification is common in neuroblastoma.
- MYCN knockdown previously shown to cause G1 arrest.
- Differential effects observed in p53 wild-type and mutant cell lines.
Purpose of the Study:
- Investigate MYCN's role in overriding the G1 checkpoint.
- Identify genes regulated by MYCN.
- Elucidate MYCN's p53-dependent and independent mechanisms.
Main Methods:
- Gene expression microarrays in MYCN amplified neuroblastoma cell lines (IMR-32, SKNBE(2c)).
- Treatment with MYCN or scrambled siRNA.
- Validation via qRT-PCR and a regulatable MYCN expression system (SHEP Tet21N).
Main Results:
- MYCN knockdown altered cell cycle gene expression.
- SKP2 was downregulated; DKK3, CDKN1C, and TP53INP1 were upregulated.
- MYCN+ Tet21N cells showed opposite regulation for SKP2 and DKK3.
Conclusions:
- MYCN may override G1 arrest by downregulating SKP2 and TP53INP1, reducing p21(WAF1) in p53 wt cells.
- MYCN may also act via the WNT pathway independently of p53 status.
- These findings highlight MYCN's complex regulation of the cell cycle in neuroblastoma.
Related Concept Videos
Master Transcription Regulators
Mitogens and the Cell Cycle
Positive Regulator Molecules
Inhibition of Cdk Activity
MicroRNAs
MicroRNAs

